Abstract
Radiolabeled nanomaterials can be used for diagnosis, therapy and theranostics of certain diseases. The core concept of radionanomedicine relies on efficient and reliable radiolabeling methods, to bind appropriate isotope with well-functionalized nanoparticles (NPs), and the use of tracer amounts of radiolabeled NPs. In this chapter, we focused on the three issues of producing radiolabeled NPs: choosing appropriate radionuclides for labeling, construction of well-functionalized NPs with surface modification and different labeling methods of NPs with radionuclides. Firstly, choosing ideal isotope starts from understanding the characteristics of each isotopes, such as half-life, decay energy and availability, and understanding of purpose of the study. Secondly, to increase the specific delivery of NPs to the target tissues while decreasing the nonspecific binding to normal tissues well functionalized NPs are necessary, which can be achieved by surface modification. Especially, micelle encapsulation method is an efficient method for producing multifunctional NPs. Finally, ideal labeling method should be adopted, which should not only be quick, easy, and highly efficient but also should not change the biological properties of target molecules. Both intrinsic and extrinsic radiolabeling methods should be chosen in the base of thorough understanding of pros and cons of each labeling methods. In conclusion, the development of the methods to enable surface labeling with ligands and chelators should be solved first. The development of the imaging methods to track the in vivo administered radiolabeled NPs is the next issue to be addressed. With the improvement of above-mentioned issues, radiolabeled NPs can be successfully translated to clinical use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
X. Sun, W. Cai, X. Chen, Positron emission tomography imaging using radiolabeled inorganic nanomaterials. Acc. Chem. Res. 48(2), 286–294 (2015)
D.S. Lee, H.J. Im, Y.S. Lee, Radionanomedicine: widened perspectives of molecular theragnosis. Nanomedicine 11(4), 795–810 (2015)
Y.-S. Lee, Y. Kim, D.S. Lee, Future perspectives of radionanomedicine using the novel micelle-encapsulation method for surface modification. Nucl. Med. Mol. Imaging 49(3), 170–173 (2015)
M. Sun, D. Hoffman, G. Sundaresan, L. Yang, N. Lamichhane, J. Zweit, Synthesis and characterization of intrinsically radiolabeled quantum dots for bimodal detection. Am. J. Nucl. Med. Mol. Imaging 2(2), 122–135 (2012)
G. Sun, J. Xu, A. Hagooly, R. Rossin, Z. Li, D.A. Moore et al., Strategies for optimized radiolabeling of nanoparticles for in vivo pet imaging. Adv. Mater. 19(20), 3157–3162 (2007)
L. Yang, G. Sundaresan, M. Sun, P. Jose, D. Hoffman, P.R. McDonagh et al., Intrinsically radiolabeled multifunctional cerium oxide nanoparticles for in vivo studies. J. Mater. Chem. B Mater. Biol. Med. 1(10), 1421–1431 (2013)
M. Zhou, R. Zhang, M. Huang, W. Lu, S. Song, M.P. Melancon et al., A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J. Am. Chem. Soc. 132(43), 15351–15358 (2010)
R.M. Wong, D.A. Gilbert, K. Liu, A.Y. Louie, Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. ACS Nano 6(4), 3461–3467 (2012)
Y. Zhao, D. Sultan, L. Detering, S. Cho, G. Sun, R. Pierce et al., Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. Angew. Chem. Int. Ed. Engl. 53(1), 156–159 (2014)
X. Lin, J. Xie, G. Niu, F. Zhang, H. Gao, M. Yang et al., Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett. 11(2), 814–819 (2011)
T.W. Liu, T.D. MacDonald, J. Shi, B.C. Wilson, G. Zheng, Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew. Chem. Int. Ed. Engl. 51(52), 13128–13131 (2012)
N. Chanda, P. Kan, L.D. Watkinson, R. Shukla, A. Zambre, T.L. Carmack et al., Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. Nanomed. (Lond.) 6(2), 201–209 (2010)
K.V. Katti, R. Kannan, K. Katti, V. Kattumori, R. Pandrapraganda, V. Rahing et al., Hybrid gold nanoparticles in molecular imaging and radiotherapy. Czech J. Phys. 56(1), D23–D34 (2006)
M.K. Khan, L.D. Minc, S.S. Nigavekar, M.S. Kariapper, B.M. Nair, M. Schipper et al., Fabrication of 198Au radioactive composite nanodevices and their use for nanobrachytherapy. Nanomed. (Lond.) 4(1), 57–69 (2008)
R. Shukla, N. Chanda, A. Zambre, A. Upendran, K. Katti, R.R. Kulkarni et al., Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc. Natl. Acad. Sci. U S A 109(31), 12426–12431 (2012)
C. Zhou, G. Hao, P. Thomas, J. Liu, M. Yu, S. Sun et al., Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics. Angew. Chem. Int. Ed. Engl. 51(40), 10118–10122 (2012)
Y. Wang, Y. Liu, H. Luehmann, X. Xia, D. Wan, C. Cutler et al., Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. Nano Lett. 13(2), 581–585 (2013)
Y. Sun, X. Zhu, J. Peng, F. Li, Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. ACS Nano 7(12), 11290–11300 (2013)
Y. Yang, Y. Sun, T. Cao, J. Peng, Y. Liu, Y. Wu et al., Hydrothermal synthesis of NaLuF4:153Sm, Yb, Tm nanoparticles and their application in dual-modality upconversion luminescence and SPECT bioimaging. Biomaterials 34(3), 774–783 (2013)
J. Zeng, B. Jia, R. Qiao, C. Wang, L. Jing, F. Wang et al., In situ 111In-doping for achieving biocompatible and non-leachable 111In-labeled Fe3O4 nanoparticles. Chem. Commun. (Camb.) 50(17), 2170–2172 (2014)
Q. Liu, Y. Sun, C. Li, J. Zhou, T. Yang, X. Zhang et al., 18F-Labeled magnetic-upconversion nanophosphors via rare-Earth cation-assisted ligand assembly. ACS Nano 5(4), 3146–3157 (2011)
Y. Sun, M. Yu, S. Liang, Y. Zhang, C. Li, T. Mou et al., Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. Biomaterials 32(11), 2999–3007 (2011)
F. Chen, P.A. Ellison, C.M. Lewis, H. Hong, Y. Zhang, S. Shi et al., Chelator-free synthesis of a dual-modality PET/MRI agent. Angew. Chem. Int. Ed. Engl. 52(50), 13319–13323 (2013)
R. Chakravarty, H.F. Valdovinos, F. Chen, C.M. Lewis, P.A. Ellison, H. Luo et al., Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging. Adv. Mater. 26(30), 5119–5123 (2014)
A.N. Mendoza-Sanchez, G. Ferro-Flores, B.E. Ocampo-Garcia, E. Morales-Avila, F. de M RamÃrez, L.M. De Leon-Rodriguez et al., Lys3-bombesin conjugated to 99mTc-labeled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging. J. Biomed. Nanotechnol. 6(4), 375–384 (2010)
E. Morales-Avila, G. Ferro-Flores, B.E. Ocampo-Garcia, L.M. De Leon-Rodriguez, C.L. Santos-Cuevas, R. Garcia-Becerra et al., Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor alpha(v)beta(3) expression. Bioconjug. Chem. 22(5), 913–922 (2011)
B.E. Ocampo-Garcia, M. Ramirez Fde, G. Ferro-Flores, L.M. De Leon-Rodriguez, C.L. Santos-Cuevas, E. Morales-Avila et al., 99mTc-labeled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection. Nucl. Med. Biol. 38(1), 1–11 (2011)
G. Zhang, Z. Yang, W. Lu, R. Zhang, Q. Huang, M. Tian et al., Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 30(10), 1928–1936 (2009)
R. Torres Martin de Rosales R, R. Tavare, A. Glaria, G. Varma, A. Protti, P.J. Blower, 99mTc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. Bioconjug. Chem. 22(3), 455–465 (2011)
W. Cai, K. Chen, Z.B. Li, S.S. Gambhir, X. Chen, Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 48(11), 1862–1870 (2007)
K. Chen, P.S. Conti, Target-specific delivery of peptide-based probes for PET imaging. Adv. Drug Deliv. Rev. 62(11), 1005–1022 (2010)
H. Xie, P. Diagaradjane, A.A. Deorukhkar, B. Goins, A. Bao, W.T. Phillips et al., Integrin alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. Int. J. Nanomed. 6, 259–269 (2011)
C. Glaus, R. Rossin, M.J. Welch, G. Bao, In vivo evaluation of 64Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug. Chem. 21(4), 715–722 (2010)
B.R. Jarrett, B. Gustafsson, D.L. Kukis, A.Y. Louie, Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug. Chem. 19(7), 1496–1504 (2008)
H.Y. Lee, Z. Li, K. Chen, A.R. Hsu, C. Xu, J. Xie et al., PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med. 49(8), 1371–1379 (2008)
Z. Liu, W. Cai, L. He, N. Nakayama, K. Chen, X. Sun et al., In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2(1), 47–52 (2007)
A.L. Petersen, T. Binderup, P. Rasmussen, J.R. Henriksen, D.R. Elema, A. Kjaer et al., 64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials 32(9), 2334–2341 (2011)
J. Guo, X. Zhang, Q. Li, W. Li, Biodistribution of functionalized multiwall carbon nanotubes in mice. Nucl. Med. Biol. 34(5), 579–583 (2007)
R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, M. Prato et al., Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U S A 103(9), 3357–3362 (2006)
M.R. McDevitt, D. Chattopadhyay, B.J. Kappel, J.S. Jaggi, S.R. Schiffman, C. Antczak et al., Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J. Nucl. Med. 48(7), 1180–1189 (2007)
R. Zhang, W. Lu, X. Wen, M. Huang, M. Zhou, D. Liang et al., Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis. J. Nucl. Med. 52(6), 958–964 (2011)
J.C. Park, M.K. Yu, G.I. An, S.I. Park, J. Oh, H.J. Kim et al., Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. Small 6(24), 2863–2868 (2010)
J. Lee, T.S. Lee, J. Ryu, S. Hong, M. Kang, K. Im et al., RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis. J. Nucl. Med. 54(1), 96–103 (2013)
J. Cao, Y. Wang, J. Yu, J. Xia, C. Zhang, D. Yin et al., Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J. Magn. Magn. Mater. 277(1–2), 165–174 (2004)
S. Liang, Y. Wang, J. Yu, C. Zhang, J. Xia, D. Yin, Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J. Mater. Sci. Mater. Med. 18(12), 2297–2302 (2007)
Y.J. Chang, C.H. Chang, T.J. Chang, C.Y. Yu, L.C. Chen, M.L. Jan et al., Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-bMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model. Anticancer Res. 27(4B), 2217–2225 (2007)
M. Luna-Gutiérrez, G. Ferro-Flores, B.E. Ocampo-GarcÃa, C.L. Santos-Cuevas, N. Jiménez-Mancilla, L.M. De León-RodrÃguez et al., A therapeutic system of 177Lu-labeled gold nanoparticles-RGD internalized in breast cancer cells. J. Mex. Chem. Soc. 57, 212–219 (2013)
Y.K. Lee, J.M. Jeong, L. Hoigebazar, B.Y. Yang, Y.-S. Lee, B.C. Lee et al., Nanoparticles modified by encapsulation of ligands with a long alkyl chain to affect multispecific and multimodal imaging. J. Nucl. Med. 53(9), 1462–1470 (2012)
W. do Hwang, H.Y. Ko, J.H. Lee, H. Kang, S.H. Ryu, I.C. Song et al., A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J. Nucl. Med. 51(1), 98–105 (2010)
I. Velikyan, Prospective of 68Ga-radiopharmaceutical development. Theranostics 4(1), 47–80 (2013)
C.J. Anderson, R. Ferdani, Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother. Radiopharm. 24(4), 379–393 (2009)
A. Niccoli Asabella, G.L. Cascini, C. Altini, D. Paparella, A. Notaristefano, G. Rubini, The copper radioisotopes: a systematic review with special interest to 64Cu. Biomed. Res. Int. 786463 (2014)
G. Fischer, U. Seibold, R. Schirrmacher, B. Wangler, C. Wangler, 89Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges. Molecules 18(6), 6469–6490 (2013)
B.L.R. Kam, J.J.M. Teunissen, E.P. Krenning, W.W. de Herder, S. Khan, E.I. van Vliet et al., Lutetium-labeled peptides for therapy of neuroendocrine tumours. Eur. J. Nucl. Med. Mol. Imaging 39(1), 103–112 (2012)
A. Sainz-Esteban, V. Prasad, C. Schuchardt, C. Zachert, J.M. Carril, R.P. Baum, Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy. Eur. J. Nucl. Med. Mol. Imaging 39(3), 501–511 (2012)
V. Goffredo, A. Paradiso, G. Ranieri, C.D. Gadaleta, Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999–2009). Crit. Rev. Oncol. Hematol. 80(3), 393–410 (2011)
H. Hong, Y. Zhang, J. Sun, W. Cai, Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today. 4(5), 399–413 (2009)
J.M. Jeong, J.K. Chung, Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials. Cancer Biother. Radiopharm. 18(5), 707–717 (2003)
L. Tian, Q. Chen, X. Yi, G. Wang, J. Chen, P. Ning et al., Radionuclide I-131 labeled albumin-paclitaxel nanoparticles for synergistic combined chemo-radioisotope therapy of cancer. Theranostics 7(3), 614–623 (2017)
M.E. Akerman, W.C. Chan, P. Laakkonen, S.N. Bhatia, E. Ruoslahti, Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. U S A 99(20), 12617–12621 (2002)
J.V. Jokerst, T. Lobovkina, R.N. Zare, S.S. Gambhir, Nanoparticle PEGylation for imaging and therapy. Nanomed. (Lond.) 6(4), 715–728 (2011)
L.E. van Vlerken, T.K. Vyas, M.M. Amiji, Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm. Res. 24(8), 1405–1414 (2007)
H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control Release 65(1–2), 271–284 (2000)
G.S. Kwon, Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Ther. Drug Carr. Syst. 20(5), 357–403 (2003)
Y. Barenholz, Doxil(R)–the first FDA-approved nano-drug: lessons learned. J. Control Release 160(2), 117–134 (2012)
J. Nam, N. Won, J. Bang, H. Jin, J. Park, S. Jung et al., Surface engineering of inorganic nanoparticles for imaging and therapy. Adv. Drug Deliv. Rev. 65(5), 622–648 (2013)
R.P. Baum, V. Prasad, D. Müller, C. Schuchardt, A. Orlova, A. Wennborg et al., Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. J. Nucl. Med. 51(6), 892–897 (2010)
O.C. Farokhzad, S. Jon, A. Khademhosseini, TNT Tran, DA LaVan, R. Langer, Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 64(21), 7668–7672 (2004)
P.E. Saw, S. Kim, Lee I-h, J. Park, M. Yu, J. Lee et al., Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy. J. Mater. Chem. B Mater. Biol. Med. 1(37), 4723–4726 (2013)
V.J. Ruigrok, M. Levisson, M.H. Eppink, H. Smidt, J. van der Oost, Alternative affinity tools: more attractive than antibodies? Biochem. J. 436(1), 1–13 (2011)
A.M. Scott, J.D. Wolchok, L.J. Old, Antibody therapy of cancer. Nat. Rev. Cancer 12(4), 278–287 (2012)
T.E. Witzig, L.I. Gordon, F. Cabanillas, M.S. Czuczman, C. Emmanouilides, R. Joyce et al., Randomized controlled trial of yttrium-90–labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed b-cell non-hodgkin’s lymphoma. J. Clin. Oncol. 20(10), 2453–2463 (2002)
R.L. Wahl, Tositumomab and (131)I therapy in non-Hodgkin’s lymphoma. J. Nucl. Med. 46(Suppl 1), 128S–140S (2005)
H. Hong, Y. Zhang, G.W. Severin, Y. Yang, J.W. Engle, G. Niu et al., Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRdye 800cw. Mol. Pharm. 9(8), 2339–2349 (2012)
R. Rezaeipoor, R. John, S.G. Adie, E.J. Chaney, M. Marjanovic, A.L. Oldenburg et al., Fc-directed antibody conjugation of magnetic nanoparticles for enhanced molecular targeting. J. Innov. Opt. Health Sci. 2(4), 387–396 (2009)
S. Kumar, J. Aaron, K. Sokolov, Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat. Protoc. 3(2), 314–320 (2008)
M.M. Cardoso, I.N. Peca, A.C. Roque, Antibody-conjugated nanoparticles for therapeutic applications. Curr. Med. Chem. 19(19), 3103–3127 (2012)
S. Jeong, J.Y. Park, M.G. Cha, H. Chang, Y.I. Kim, H.M. Kim et al., Highly robust and optimized conjugation of antibodies to nanoparticles using quantitatively validated protocols. Nanoscale 9(7), 2548–2555 (2017)
H. Wang, Y.L. Liu, Y.H. Yang, T. Deng, G.L. Shen, R.Q. Yu, A protein A-based orientation-controlled immobilization strategy for antibodies using nanometer-sized gold particles and plasma-polymerized film. Anal. Biochem. 324(2), 219–226 (2004)
S. Mazzucchelli, M. Colombo, C. De Palma, A. Salvade, P. Verderio, M.D. Coghi et al., Single-domain protein a-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells. ACS Nano 4(10), 5693–5702 (2010)
A. Makaraviciute, A. Ramanaviciene, Site-directed antibody immobilization techniques for immunosensors. Biosens. Bioelectron. 50, 460–471 (2013)
M. Salehi, L. Schneider, P. Strobel, A. Marx, J. Packeisen, S. Schlucker, Two-color SERS microscopy for protein co-localization in prostate tissue with primary antibody-protein A/G-gold nanocluster conjugates. Nanoscale 6(4), 2361–2367 (2014)
B. Dubertret, P. Skourides, D.J. Norris, V. Noireaux, A.H. Brivanlou, A. Libchaber, In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298(5599), 1759–1762 (2002)
H. Fan, K. Yang, D.M. Boye, T. Sigmon, K.J. Malloy, H. Xu et al., Self-assembly of ordered, robust, three-dimensional gold nanocrystal/silica arrays. Science 304(5670), 567–571 (2004)
H. Fan, E.W. Leve, C. Scullin, J. Gabaldon, D. Tallant, S. Bunge et al., Surfactant-assisted synthesis of water-soluble and biocompatible semiconductor quantum dot micelles. Nano Lett. 5(4), 645–648 (2005)
O. Carion, B. Mahler, T. Pons, B. Dubertret, Synthesis, encapsulation, purification and coupling of single quantum dots in phospholipid micelles for their use in cellular and in vivo imaging. Nat. Protoc. 2(10), 2383–2390 (2007)
H. Wu, H. Zhu, J. Zhuang, S. Yang, C. Liu, Y.C. Cao, Water-soluble nanocrystals through dual-interaction ligands. Angew. Chem. Int. Ed. Engl. 47(20), 3730–3734 (2008)
A. Samanta, K.K. Maiti, K.S. Soh, X. Liao, M. Vendrell, U.S. Dinish et al., Ultrasensitive near-infrared Raman reporters for SERS-based in vivo cancer detection. Angew. Chem. Int. Ed. Engl. 50(27), 6089–6092 (2011)
B.-H. Jun, D.W. Hwang, H.S. Jung, J. Jang, H. Kim, H. Kang et al., Ultrasensitive, biocompatible, quantum-dot-embedded silica nanoparticles for bioimaging. Adv. Funct. Mater. 22(9), 1843–1849 (2012)
B.Y. Yang, S.H. Moon, S.R. Seelam, M.J. Jeon, Y.S. Lee, D.S. Lee et al., Development of a multimodal imaging probe by encapsulating iron oxide nanoparticles with functionalized amphiphiles for lymph node imaging. Nanomed. (Lond.) 10(12), 1899–1910 (2015)
D.S. Lee, Preparation of multifunctional multimodal nanoparticles using specific amphiphiles: click chemistry for nanoparticles. Annu. Congress Clinam (Abstr.) (2013)
D.S. Lee, In vivo application of Cu-64 labeled upconversion nanoparticles. Annu. Congress Clinam (Abstr.) (2014)
H. Kang, S. Jeong, Y. Park, J. Yim, B.-H. Jun, S. Kyeong et al., Near-infrared SERS nanoprobes with plasmonic Au/Ag hollow-shell assemblies for in vivo multiplex detection. Adv. Funct. Mater. 23(30), 3719–3727 (2013)
K. Susumu, H.T. Uyeda, I.L. Medintz, T. Pons, J.B. Delehanty, H. Mattoussi, Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands. J. Am. Chem. Soc. 129(45), 13987–13996 (2007)
J. Hrkach, D. Von Hoff, M. Mukkaram Ali, E. Andrianova, J. Auer, T. Campbell et al., Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med. 4(128), 128ra39 (2012)
F. Danhier, B. Vroman, N. Lecouturier, N. Crokart, V. Pourcelle, H. Freichels et al., Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J. Control Release 140(2), 166–173 (2009)
D. Sarko, M. Eisenhut, U. Haberkorn, W. Mier, Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases. Curr. Med. Chem. 19(17), 2667–2688 (2012)
Y. Xing, J. Zhao, P.S. Conti, K. Chen, Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics 4(3), 290–306 (2014)
G.F.F. Enrique Morales-Avila, B.E. Ocampo-GarcÃa, F. de MarÃa RamÃrez, Radiolabeled Nanoparticles for Molecular Imaging, ed. by B. Schaller. (InTech) (2012)
T.J. Wadas, E.H. Wong, G.R. Weisman, C.J. Anderson, Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem. Rev. 110(5), 2858–2902 (2010)
Y.-S. Lee, in Radiopharmaceutical Chemistry, ed. by E.E. Kim, U. Tateishi, R. Baum. Handbook of Nuclear Medicine and Molecular Imaging (World Scientific Publishing Co. Pte. Ltd, NJ, 2012) pp. 21–51
W.T. Phillips, B.A. Goins, A. Bao, Radioactive liposomes. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(1), 69–83 (2009)
S. Jeger, K. Zimmermann, A. Blanc, J. Grunberg, M. Honer, P. Hunziker et al., Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase. Angew. Chem. Int. Ed. Engl. 49(51), 9995–9997 (2010)
S. Goel, F. Chen, E.B. Ehlerding, W. Cai, Intrinsically radiolabeled nanoparticles: an emerging paradigm. Small 10(19), 3825–3830 (2014)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Lee, D.S., Suh, M., Lee, YS. (2018). Radiolabeling Method: Core/Surface Labeling, Chemical and Physical Labeling. In: Lee, D. (eds) Radionanomedicine. Biological and Medical Physics, Biomedical Engineering. Springer, Cham. https://doi.org/10.1007/978-3-319-67720-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-67720-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67719-4
Online ISBN: 978-3-319-67720-0
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)